CHB Global X China Biotech Innovation ETF
Solactive China Biotech Inno NR USD

NAV as of 02-Dec-2022

9.5800

4 Week: 9.03 - 9.85

52 Week: 8.04 - 15.64

Latest Closing Price

9.74

Premium / Discount

0.75

Expense Ratio

0.65%

Investment Objective

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("underlying index"). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China’s biotechnology industry. It is non-diversified.

Main Fund Characteristics

Fund Manager:
Global X Funds
Asset Under Management:
2,582,342
Launch Date:
21/09/2020
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
32
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
China / N.A / N.A
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-31.172.29-13.63
1 Day2.550.000.00
1 Week7.626.121.25
1 Month9.4412.780.74
3 Months-0.9523.41-0.04
6 Months0.4627.240.02
1 Year-37.1236.03-1.03
2 Years-35.0246.87-0.75
3 Years0.000.000.00
5 Years0.000.000.00
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.0000-12.0024
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.000058.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
28/06/202207/07/20220.0199

Portfolio Data

Total Number of Holdings: 32

Number of Bond Holdings: 0

Number of Equity Holdings: 30

Total Market Value: 2,582,342

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
N.A

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant17.79
Large48.32
Medium27.77
Small5.99
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.5096

Price/Book*

2.7178

Price/Sales*

3.9346

Price/Cash Flow*

15.4789

Dividend Yield*

2.1741

Growth Measures

Long-Term Earnings

12.3499

Historical Earnings

32.5078

Sales Growth

25.1184

Cash-Flow Growth

43.4136

Book-Value Growth

21.8502

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.